Cargando…

Newborn Screening for Fabry Disease in Northeastern Italy: Results of Five Years of Experience

Fabry disease (FD) is a progressive multisystemic lysosomal storage disease. Early diagnosis by newborn screening (NBS) may allow for timely treatment, thus preventing future irreversible organ damage. We present the results of 5.5 years of NBS for FD by α-galactosidase A activity and globotriaosyls...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gragnaniello, Vincenza, Burlina, Alessandro P, Polo, Giulia, Giuliani, Antonella, Salviati, Leonardo, Duro, Giovanni, Cazzorla, Chiara, Rubert, Laura, Maines, Evelina, Germain, Dominique P, Burlina, Alberto B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301924/ https://www.ncbi.nlm.nih.gov/pubmed/34199132 http://dx.doi.org/10.3390/biom11070951

Ejemplares similares

Implementation of Second-Tier Tests in Newborn Screening for Lysosomal Disorders in North Eastern Italy
por: Burlina, Alberto B., et al.
Publicado: (2019)

Report of Five Years of Experience in Neonatal Screening for Mucopolysaccharidosis Type I and Review of the Literature
por: Gragnaniello, Vincenza, et al.
Publicado: (2020)

Newborn screening for Pompe disease in Italy: Long-term results and future challenges
por: Gragnaniello, Vincenza, et al.
Publicado: (2022)

Newborn Screening for Fabry Disease: Current Status of Knowledge
por: Gragnaniello, Vincenza, et al.
Publicado: (2023)

Bone disease in early detected Gaucher Type I disease: A case report
por: Gragnaniello, Vincenza, et al.
Publicado: (2022)

Unusual Evolution of Hypertrophic Cardiomyopathy in Non-Compaction Myocardium in a Pompe Disease Patient
por: Gragnaniello, Vincenza, et al.
Publicado: (2023)

A new strategy of desensitization in mucopolysaccharidosis type II disease treated with idursulfase therapy: A case report and review of the literature
por: Gragnaniello, Vincenza, et al.
Publicado: (2022)

Nervous system and Fabry disease, from symptoms to diagnosis: damage evaluation and follow-up in adult patients, enzyme replacement, and support therapy
por: Salviati, Alessandro, et al.
Publicado: (2010)

Abnormal activation of MAPKs pathways and inhibition of autophagy in a group of patients with Zellweger spectrum disorders and X-linked adrenoleukodystrophy
por: Gragnaniello, Vincenza, et al.
Publicado: (2023)

FAbry STabilization indEX (FASTEX): an innovative tool for the assessment of clinical stabilization in Fabry disease
por: Mignani, Renzo, et al.
Publicado: (2016)

Large Neutral Amino Acid Therapy Increases Tyrosine Levels in Adult Patients with Phenylketonuria: A Long-Term Study
por: Burlina, Alessandro P., et al.
Publicado: (2019)

Congenital hyperinsulinism in clinical practice: From biochemical pathophysiology to new monitoring techniques
por: Martino, Mariangela, et al.
Publicado: (2022)

Food triggers and inherited metabolic disorders: a challenge to the pediatrician
por: Maines, Evelina, et al.
Publicado: (2018)

Understanding the Pathogenesis of Cardiac Complications in Patients with Propionic Acidemia and Exploring Therapeutic Alternatives for Those Who Are Not Eligible or Are Waiting for Liver Transplantation
por: Maines, Evelina, et al.
Publicado: (2023)

The Impact of a Slow-Release Large Neutral Amino Acids Supplement on Treatment Adherence in Adult Patients with Phenylketonuria
por: Burlina, Alessandro P., et al.
Publicado: (2020)

Clinical experience with N-carbamylglutamate in a single-centre cohort of patients with propionic and methylmalonic aciduria
por: Burlina, Alberto, et al.
Publicado: (2016)

Newborn screening in mucopolysaccharidoses
por: Donati, Maria Alice, et al.
Publicado: (2018)

Quality of Life (QoL) assessment in a cohort of patients with Phenylketonuria
por: Cazzorla, Chiara, et al.
Publicado: (2014)

Correction to: Newborn screening in mucopolysaccharidoses
por: Donati, Maria Alice, et al.
Publicado: (2019)

Pain in Fabry Disease: Practical Recommendations for Diagnosis and Treatment
por: Politei, Juan M., et al.
Publicado: (2016)

Fabry disease and multiple sclerosis misdiagnosis: the role of family history and neurological signs
por: Colomba, Paolo, et al.
Publicado: (2018)

Neonatal Expanded Screening toward lysosomal storage disorders
por: Burlina, Alberto, et al.
Publicado: (2015)

The Utility of CSF for the Diagnosis of Primary and Secondary Monoamine Neurotransmitter Deficiencies
por: Burlina, A.B., et al.
Publicado: (2017)

Fabry disease
por: Germain, Dominique P
Publicado: (2010)

Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study
por: Germain, Dominique P., et al.
Publicado: (2018)

Expert opinion of an Italian working group on the assessment of cognitive, psychological, and neurological outcomes in pediatric, adolescent, and adult patients with phenylketonuria
por: Manti, Filippo, et al.
Publicado: (2022)

Correction: Expert opinion of an Italian working group on the assessment of cognitive, psychological, and neurological outcomes in pediatric, adolescent, and adult patients with phenylketonuria
por: Manti, Filippo, et al.
Publicado: (2023)

Living with phenylketonuria in adulthood: The PKU ATTITUDE study
por: Cazzorla, Chiara, et al.
Publicado: (2018)

Fabry disease and COVID-19: International expert recommendations for management based on real-world experience
por: Laney, Dawn A., et al.
Publicado: (2021)

Fabry disease and COVID-19: international expert recommendations for management based on real-world experience
por: Laney, Dawn A, et al.
Publicado: (2020)

Expanded Newborn Screening in Italy Using Tandem Mass Spectrometry: Two Years of National Experience
por: Ruoppolo, Margherita, et al.
Publicado: (2022)

Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease?
por: Duro, Giovanni, et al.
Publicado: (2018)

Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel
por: Burlina, Alessandro P, et al.
Publicado: (2011)

Health-related quality of life in a european sample of adults with early-treated classical PKU
por: Maissen-Abgottspon, Stephanie, et al.
Publicado: (2023)

Genomic screening of Fabry disease in young stroke patients: the Taiwan experience and a review of the literature
por: Lee, T.‐H., et al.
Publicado: (2018)

Niemann–Pick disease type C: introduction and main clinical features
por: Burlina, A.
Publicado: (2014)

Five-year performance analysis of a cystic fibrosis newborn screening program in northeastern Brazil
por: Godoy, Carolina, et al.
Publicado: (2022)

Italian national consensus statement on management and pharmacological treatment of phenylketonuria
por: Burlina, Alberto, et al.
Publicado: (2021)

Tickborne Encephalitis Virus, Northeastern Italy
por: Beltrame, Anna, et al.
Publicado: (2006)

Immune responses to alglucosidase in infantile Pompe disease: recommendations from an Italian pediatric expert panel
por: Gragnaniello, Vincenza, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r13l0scdme8aq02vff5ktq433j